Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation
Justin Schaffer(Johns Hopkins University), John V. Conte(Commonwealth Medical College), Stuart D. Russell(Duke Medical Center), Ashish S. Shah(Vanderbilt University Medical Center), Nishant Patel(Johns Hopkins University), Eric S. Weiss(University of Pittsburgh), Jeremiah G. Allen(Johns Hopkins University), George J. Arnaoutakis(Dell Children's Medical Center of Central Texas)
Cited by 122
Related Papers
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients
|Journal of the American College of Cardiology|2010|583
Reduced Kidney Function as a Risk Factor for Incident Heart Failure
|Journal of the American Society of Nephrology|2007|449